Zhang et al. (2024) demonstrated that the RNA-binding protein POP1 promotes TNBC proliferation through m6A-dependent degradation of CDKN1A mRNA, identifying a potential therapeutic role for the m6A inhibitor STM2457 in suppressing tumor growth [42]. This evidence concerns the gene CDKN1A and neoplasm.